Globus Medical Inc Stock News

Globus Medical (GMED) U.S. sales increase, driven by competitive rep conversions and robotic pull-through.

Globus Medical makes surgery faster and safer.

Globus Medical continues to offer compelling long-term value with its expertise in spinal and musculoskeletal surgery. With its entry into robotics and emerging technologies continuing to ramp up, the

Globus Medical's (GMED) Musculoskeletal Solutions products generate solid revenues on growth in spine and trauma implant portfolios.

Globus Medical, Inc. (NYSE:GMED ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Brian Kearns - SVP, Business Development & IR Daniel Scavilla - President, CEO & Direc

Globus Medical (GMED) delivered earnings and revenue surprises of 3.70% and 2%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

AUDUBON, Pa., July 18, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30,

Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?

Globus Medical's (GMED) strong international growth and meaningful product launches raise investors' optimism.

Globus Medical has the credentials to outstrip peers in the shifting rates/inflation regime. The stock has traded down in recent times, widening up the value proposition.

Globus Medical's (GMED) Excelsius3D, when combined with ExcelsiusGPS, facilitates greater implant placement accuracy, lowers radiation exposure and reduces operative times.

According to Globus Medical (GMED), its Q1 results reflect modest revenue growth against a difficult prior-year comparison, coupled with COVID-related revenue impacts in key countries.

Globus Medical (GMED) delivered earnings and revenue surprises of -8.70% and 1.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Globus Medical, Inc. (NYSE:GMED ) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Brian Kearns - Senior Vice President, Business Development & Investor Relations Dan Scav

Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.